The Next Generation Drug Conjugate Market is estimated to be worth USD $15.47 billion in 2035, predicts Roots Analysis

As a result of the recent advancement in drug development technologies, coupled with the rising demand of drugs and therapies for untreatable disorders have enabled the development of number of next generation drug conjugates that are capable of curing a rare therapeutic indication, including cancer.

Roots Analysis is pleased to announce the publication of its recent study, titled, "Next Generation Drug Conjugates Market

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/next-generation-drug-conjugates-market/request-quote.html

The report features an extensive study of the current market landscape, market size and future opportunities associated with the next generation drug conjugate market, during the given forecast period. Key takeaways of the next generation drug conjugates market report includes:

1. An executive summary of the insights captured during our research.
2. A general overview of the next generation drug conjugates, highlighting details on their constituent components such as targeting ligand, payload, route of administration and others.
3. A detailed assessment of the current pipeline of the next generation drug conjugates and a detailed market landscape of the companies engaged in the development of these conjugates, based on several relevant parameters.
4. Elaborate profiles of the prominent companies (shortlisted based on a proprietary criterion) engaged in the development of next generation drug conjugates.
5. An insightful clinical trial analysis of completed / ongoing clinical trials on next generation drug conjugates, based on various relevant parameters.
6. A detailed analysis of the partnerships inked between stakeholders in the next generation drug conjugates market, since 2018.
7. An analysis of the grants awarded by the stakeholders to support the ongoing R&D efforts and innovations in the field of next generation drug conjugates.
8. A detailed analysis of the various publications focused on research related to the next generation drug conjugates utilizing various types of targeting ligand, payload, route of administration and others.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/next-generation-drug-conjugates-market/request-sample.html

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of Conjugate
1. Peptide-Radionuclide Conjugate
2. Ligand Mediated RNAi Conjugate
3. Ligand Conjugated Anti Sense Medicine
4. Peptide Drug Conjugate

Type of Targeting Ligand
1. Amino Sugar
2. Peptide
3. Lipids

Type of Payload
1. Radionuclide
2. Drugs
3. Antisense Oligonucleotide
4. si-RNA

Type of Therapy
1. Monotherapy
2. Combination Therapy

Route of Administration
1. Subcutaneous
2. Intravenous

Target Disease Indications
1. Gastroenteropancreatic Neuroendocrine Tumor
2. Prostate Cancer
3. Leptomeningeal Carcinomatosis
4. Hereditary Transthyretin Amyloidosis
5. Atherosclerotic Cardiovascular Disease
6. Severe Hypertriglyceridemia
7. Sleep Disorders
8. Hereditary Angioedema
9. Acute Hepatic Porphyria
10. Primary Hyperoxaluria
11. Heterozygous Familial Hypercholesterolemia
12. Hemophilia
13. Low Risk Myelodysplastic Syndrome
14. Myelofibrosis
15. Alpha-1 Antitrypsin Deficiency Liver Disease
16. Familial Chylomicronemia Syndrome

Key Geographical Regions
1. North America
2. Europe
3. Asia-Pacific and Rest of the world

Key companies covered in the report
1. Advanced Accelerator Applications
2. Alnylam Pharmaceuticals
3. Arrowhead Pharmaceuticals
4. Dicerna Pharmaceuticals
5. Geron
6. Ionis Pharmaceuticals

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/next-generation-drug-conjugates-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.